Cardiothoracic Surgery Overview

Principles

Definition

Cardiothoracic surgery is a medical specialty and research field focused on the surgical treatment of diseases and conditions affecting the heart, lungs, and other organs within the chest cavity. This discipline investigates advanced surgical techniques, perioperative management, and patient outcomes for complex intrathoracic pathologies.

Ontological type

Core Procedures

Surgical Techniques

Perioperative Management

Key developments

Key Figures

Foundational Reconstruction and Bypass era

Denton A. Cooley [1], who trained and practiced across Johns Hopkins University [3] and Baylor College of Medicine [4] during the Foundational Reconstruction era, emerged as a leading figure in structural heart surgery. His key contributions included pioneering surgical management of dissecting aneurysm of the aorta [7], intrathoracic aneurysms of the aorta and great vessels [8], and the development of controlled extracorporeal circulation in surgical treatment of aortic aneurysm [9], which together established viable repair strategies under bypass and transformed postoperative care. Oscar Creech [2] operated across Tulane University [5] and Baylor University [6] during this era, contributing to early progress in aortic surgery. Creech's work, including the 1955 Surgical Considerations of Dissecting Aneurysm of the Aorta [7], helped to advance understanding of aortic pathology and supported the adoption of extracorporeal techniques that underpinned the era's reconstructive capabilities.

Surgical Optimization and Risk Stratification era

E. Stanley Crawford [1] was associated with Johns Hopkins University [3] and Baylor College of Medicine [4] during this era. Crawford [1] contributed to the systematic analysis of large thoracoabdominal aortic operation series, exemplified by experience with 1509 patients [6] and by identifying preoperative and intraoperative factors determining immediate and long‑term results in 605 patients [7], which helped shift practice toward risk‑adjusted, outcome‑based optimization. Hazim J. Safi [2] was affiliated with Baylor College of Medicine [4] and Yale University [5] during this era. Safi [2] contributed to the thoracoabdominal aneurysm studies by clarifying preoperative and intraoperative determinants of outcomes in 605 patients [7] and 1509 cases [6], reinforcing the move toward evidence‑based risk stratification and standardized reporting of perioperative results in this era.

Transcatheter and Endovascular Revolution era

Martin B. Leon[1] is a leading figure in cardiothoracic surgery during the Transcatheter and Endovascular Revolution era, with affiliations at Harvard University[3] and the Massachusetts Institute of Technology[4]. His key contributions in this era include pivotal transcatheter aortic-valve trials and device innovations, notably Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery[7], Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients[8], and the Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery[9], which together defined feasibility, expanded indications, and the role of drug-eluting devices in percutaneous therapy. John G. Webb[2] with affiliations at Stanford University[5] and the University of Pennsylvania[6] contributed significantly to the era's evidence base and multidisciplinary collaboration. His work during this era includes the same pivotal trials and comparative analyses that shaped practice, notably Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery[7], Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients[8], and Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement[10], which provided essential durability and comparative-effectiveness data driving guideline updates.